Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (461-470 of 659) with videos related to

Pageof 66
Sort By:
HIV Medicine|October 9, 2008
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008A de Ruiter, D Mercey, J Anderson, et al.
British Journal of Haematology|June 16, 2017
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.
Infection Control and Hospital Epidemiology|February 27, 2003
A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993-1995Francisco Alvarado-Ramy, Elise M Beltrami, Louise J Short, et al.
American Journal of Hematology|February 13, 2021
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemiaSangeetha Venugopal, Abhishek Maiti, Courtney D DiNardo, et al.
Cancer|January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
American Journal of Hematology|April 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burdenMusa Yilmaz, Naval Daver, Gautam Borthakur, et al.
American Journal of Hematology|April 13, 2024
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implicationsTareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expressionElias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Cancer|March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemiaFadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
American Journal of Hematology|March 31, 2022
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitorsFadi G Haddad, Koji Sasaki, Ghayas C Issa, et al.
Pageof 66

Showing results (461-470 of 659) with videos related to

Sort By:
Pageof 66
HIV Medicine|October 9, 2008
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008A de Ruiter, D Mercey, J Anderson, et al.
British Journal of Haematology|June 16, 2017
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.
Infection Control and Hospital Epidemiology|February 27, 2003
A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993-1995Francisco Alvarado-Ramy, Elise M Beltrami, Louise J Short, et al.
American Journal of Hematology|February 13, 2021
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemiaSangeetha Venugopal, Abhishek Maiti, Courtney D DiNardo, et al.
Cancer|January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
American Journal of Hematology|April 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burdenMusa Yilmaz, Naval Daver, Gautam Borthakur, et al.
American Journal of Hematology|April 13, 2024
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implicationsTareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expressionElias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Cancer|March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemiaFadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
American Journal of Hematology|March 31, 2022
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitorsFadi G Haddad, Koji Sasaki, Ghayas C Issa, et al.
Pageof 66